BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11533107)

  • 1. Validation of the ucla integrated staging system for patients with renal cell carcinoma.
    Zisman A; Pantuck AJ; Figlin RA; Belldegrun AS
    J Clin Oncol; 2001 Sep; 19(17):3792-3. PubMed ID: 11533107
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Kattan MW
    Urology; 2010 Jun; 75(6):1371; author reply 1371-2. PubMed ID: 20513496
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment.
    Pomara G; Francesca F
    Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.
    Han KR; Bleumer I; Pantuck AJ; Kim HL; Dorey FJ; Janzen NK; Zisman A; Dinney CP; Wood CG; Swanson DA; Said JW; Figlin RA; Mulders PF; Belldegrun AS
    J Urol; 2003 Dec; 170(6 Pt 1):2221-4. PubMed ID: 14634383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of simplified versions of the Fuhrman nuclear grading system in clinical practice requires the agreement of a multidisciplinary panel of experts.
    Ficarra V; Novara G; Martignoni G
    Eur Urol; 2009 Nov; 56(5):782-4; discussion 784-5. PubMed ID: 19660853
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on pathologic staging of renal cell carcinoma.
    Gettman MT; Blute ML
    Urology; 2002 Aug; 60(2):209-17. PubMed ID: 12137811
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of nephron-sparing surgery for renal cell carcinoma.
    Novick AC
    Eur Urol; 1990; 18 Suppl 2():24-5. PubMed ID: 2226600
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
    Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW
    Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
    Sun M; Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Pharand D; Latour M; Perrotte P; Patard JJ; Karakiewicz PI
    Eur Urol; 2009 Nov; 56(5):775-81. PubMed ID: 19573980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 11. Staging and survival of patients with renal cell carcinoma.
    Guinan P; Frank W; Saffrin R; Rubenstein M
    Semin Surg Oncol; 1994; 10(1):47-50. PubMed ID: 8115785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative surgery of kidney tumors.
    Selli C; Lapini A; Carini M
    Prog Clin Biol Res; 1991; 370():9-17. PubMed ID: 1924484
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
    Belldegrun A; Tsui KH; deKernion JB; Smith RB
    J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in renal cell cancer.
    Park WH; Eisen T
    BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controversies in surgical therapy of renal cell carcinoma].
    Schröder A; Lampel A; Eggersmann C; Thüroff JW
    Urologe A; 1997 Sep; 36(5):W460-6. PubMed ID: 9424788
    [No Abstract]   [Full Text] [Related]  

  • 17. [Kidney parenchyma carcinoma--diagnosis. German Society of Urology].
    Urologe A; 1998 May; 37(3):328-41. PubMed ID: 9646432
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognostic parameters in renal cell carcinoma--a new approach. 1989].
    Störkel S; Thoenes W; Jacobi GH; Lippold R
    Aktuelle Urol; 2004 Feb; 35(1):18-21. PubMed ID: 15046020
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal cell carcinoma: blood transfusion and survival.
    Manyonda IT; Shaw DE; Foulkes A; Osborn DE
    Br Med J (Clin Res Ed); 1986 Aug; 293(6546):537-8. PubMed ID: 3092905
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal cell carcinoma: vena caval involvement.
    Boorjian SA; Sengupta S; Blute ML
    BJU Int; 2007 May; 99(5 Pt B):1239-44. PubMed ID: 17441917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.